2024 Sustainability Progress Update
Advancing sustainability in animal health for a better future.
Our aspirations provide a roadmap across our three pillars—Communities, Animals, and Planet—for how Zoetis can help build a healthier future for all.
Communities
We support and partner with our colleagues, communities and the people who care for animals. We achieve more by working together toward our common goals.
ASPIRATION
Create a sustainable governance framework
TARGET
Integrate sustainability into our strategic planning and resource allocation process
STATUS
On track
2024 PROGRESS
Continued incorporation of sustainability goals in our key business functions.
Our Executive Team members continue to have shared and individual objectives under our annual incentive plan organized around our six strategic priorities, one of which is: Advance Sustainability in Animal Health for a Better Future. Please see our 2025 proxy statement for additional information regarding these goals.
TARGET
Establish an effective approach to external sustainability disclosures
STATUS
On track
2024 PROGRESS
Continued to report in line with best practice sustainability frameworks.
Engaged with stakeholders to advance our program and disclosures.
Developed working groups and processes to meet evolving regulatory disclosure requirements and enhanced processes to streamline and centralize reporting.
ASPIRATION
Support our communities
TARGET
Contribute 2,500 volunteer days (20,000 hours) annually in the communities we serve
STATUS
On track
2024 PROGRESS
20,404 hours of volunteer time reported by our colleagues, 102% of our stated goal. This is a 23% increase from hours reported in 2023.
ASPIRATION
Support veterinary professionals
TARGET
Provide at least $1 million in scholarships to veterinary students annually
STATUS
On track
2024 PROGRESS
The Zoetis Foundation provided grants of $3.5 million in 2024, for scholarships to support nearly 500 students.
TARGET
Provide access to professional programs for veterinarians in the countries where we have a presence
STATUS
On track
2024 PROGRESS
Zoetis continued to invest in professional programs in 100% of our markets where we have a physical presence, through Zoetis-led programs and through partnerships with external organizations.
ASPIRATION
Expand vet care access to populations in need
TARGET
Annually report on the number of pet owners reached through community programs and in-kind contributions
STATUS
On track
2024 PROGRESS
Zoetis’ efforts impacted approximately 322,000 pet owners in need.
ASPIRATION
Provide animal care in disaster relief
TARGET
Annually report on the number of pet owners reached through community programs and in-kind contributions
STATUS
On track
2024 PROGRESS
Zoetis’ efforts impacted approximately 428,000 animals affected by disasters.
Our aspirations provide a roadmap across our three pillars—Communities, Animals, and Planet—for how Zoetis can help build a healthier future for all.
Animals
Some of humanity’s greatest challenges continue to emerge at the intersection of human, animal, environmental and economic health. By enhancing the health and welfare of animals, we contribute to thriving communities and ecosystems through deepening bonds with our pets, protecting wildlife, and strengthening farmer livelihoods and global food security.
ASPIRATION
Provide products and services that enable productive and sustainable livestock farms that preserve animal welfare
TARGET
Innovate to create and drive adoption of key sustainable animal health solutions
STATUS
On track
2024 PROGRESS
Collaborated across the value chain to develop data to support adoption of sustainable animal health and genomics solutions.
TARGET
Equip our customers with innovative products to support their ambitious environmental, social and animal welfare goals
STATUS
On track
2024 PROGRESS
Launched new solutions to support healthy, sustainable livestock farming and expanded franchises.
ASPIRATION
Promote a preventive approach to animal health with positive implications on human health
TARGET
Promote responsible use of antibiotics through technical education, introducing antibiotic alternatives, and developing diagnostic and digital tools
STATUS
On track
2024 PROGRESS
Joined cross-industry collaborative groups to develop and promote best-practice antimicrobial stewardship.
TARGET
Innovate around antimicrobial resistance to reduce the dependency on antibiotic classes shared with human health
STATUS
On track
2024 PROGRESS
Launched a new diagnostic product and invested in research to better target treatment against common livestock diseases.
ASPIRATION
Grow access to vet care in emerging markets
TARGET
Through our A.L.P.H.A. and A.L.P.H.A. Plus initiatives with focus in Africa, by the end of 2025 we will: Train 100,000 farmers, vet professionals and lab technicians
STATUS
Not on track, but mitigation measures are in place
2024 PROGRESS
Delivered 75,766 trainings to farmers, veterinarians, para-veterinarians, distributors and lab technicians.1
TARGET
Treat 10 million cows, with positive implications on smallholder livelihoods, food security and the environment
STATUS
On track
2024 PROGRESS
Treated 16.7 million cows, exceeded goal by 67%.2,3
TARGET
Treat 200 million chickens, with positive implications on smallholder livelihoods, food security and the environment
STATUS
On track
2024 PROGRESS
Treated 354.9 million chickens, exceeded goal by 77%.2,4
ASPIRATION
Combat diseases that pose the greatest risk to animals and humans
TARGET
Leverage the Zoetis Center for Transboundary and Emerging Diseases to develop vaccines for high-impact emerging diseases globally: Invest in R&D on emerging infectious diseases
STATUS
On track
2024 PROGRESS
Progressed research and development of vaccines targeting HPAI H5N1.
TARGET
Provide our innovative vaccines to relevant markets via tenders or other go-to-market pathways
STATUS
On track
2024 PROGRESS
Supported endangered species protection programs.
Collaborated to support One Health initiatives.
1 Progress shown is from 2019 through November 2024. Numbers reflect training attendance and may not represent unique individuals.
2 Progress shown is from 2020 through November 2024.
3 Assumes that each cow received at least two doses (treatment and prevention).
4 Assumes that each chicken received at least five doses (treatment and prevention).
Our aspirations provide a roadmap across our three pillars—Communities, Animals, and Planet—for how Zoetis can help build a healthier future for all.
Planet
At Zoetis, we have committed to minimizing our carbon footprint, rethinking our packaging and improving sustainability across our locations. Our dedication is driven by our responsibility to the communities we serve, our colleagues, our customers, the health of animals and those who care for them around the world.
ASPIRATION
Minimize our carbon footprint1
TARGET
Become carbon neutral in our own operations by 2030
STATUS
On track
2024 PROGRESS
36.1% reduction in Scope 1 and 2 emissions.2
Completed 28 energy-related carbon reduction projects at our sites in 2024.
TARGET
Source 100% renewable electricity by 2030
STATUS
On track
2024 PROGRESS
80.6% renewable electricity sourced to date aligned with our RE100 commitment.3
On-site solar arrays now installed at eight Zoetis facilities.
TARGET
Rethink business travel and work-from-home policies to reduce transportation-related emissions by 25% by 20254
STATUS
On track
2024 PROGRESS
Reduced colleague transportation-related emissions intensity by 31.6%.
ASPIRATION
Rethink our packaging to reduce its environmental impact
TARGET
Integrate sustainability considerations into all new packaging designs
STATUS
On track
2024 PROGRESS
Advanced our sustainable packaging strategy through innovative initiatives in product and shipping packaging.
ASPIRATION
Improve the sustainability in our locations
TARGET
Stand-up “Location Sustainability” teams in major sites
STATUS
On track
2024 PROGRESS
All major manufacturing and two R&D sites have sustainability teams with specific objectives.
Pharmaceuticals in the Environment
Zoetis is committed to minimizing the environmental impact of our products, and this includes actively working to mitigate the presence of pharmaceuticals in the environment. Click here to learn more.
1 Our carbon footprint and energy data was updated at the end of 2024 to remove operations that were part of the MFA divestiture.
2 Using 2021 as the base year and reported through December 31, 2024. For additional details on our greenhouse gas (GHG) emissions, such as inclusions and exclusions, see our Environment Data.
3 Renewable electricity is aligned to our RE100 commitment and is the proportion of renewable electricity relative to total Scope 2 electricity use and reported through December 31, 2024.
4 Using 2019 as the base year. Reduction reported is total of business travel and colleague commuting normalized by number of colleagues for respective reporting year.